Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2006 Jan 17;78(3):408–416. doi: 10.1002/jmv.20555

Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients

Giuseppe Gerna 1,✉, Patrizio Vitulo 3, Francesca Rovida 1, Daniele Lilleri 1, Carlo Pellegrini 2, Tiberio Oggionni 3, Giulia Campanini 1, Fausto Baldanti 1, M Grazia Revello 1
PMCID: PMC7166633  PMID: 16419110

Abstract

Viral respiratory tract infections in lung transplant recipients may be severe. During three consecutive winter‐spring seasons, 49 symptomatic lung transplant recipients with suspected respiratory viral infection, and 26 asymptomatic patients were investigated for presence of respiratory viruses either in 56 nasopharyngeal aspirate or 72 bronchoalveolar lavage samples taken at different times after transplantation. On the whole, 1 asymptomatic (3.4%) and 28 symptomatic (57.1%) patients were positive for human metapneumovirus (hMPV, 4 patients), influenza virus A (3 patients), and B (2 patients), respiratory syncytial virus (2 patients), human coronavirus (2 patients), human parainfluenza virus (2 patients), rhinovirus (5 patients), while 4 patients were coinfected by 2 respiratory viruses, and 5 were infected sequentially by 2 or more respiratory viruses. In bronchoalveolar lavage samples, hMPV predominated by far over the other viruses, being responsible for 60% of positive specimens, whereas other viruses were present in nasopharyngeal aspirates at a comparable rate. RT‐PCR (detecting 43 positive samples/128 examined) was largely superior to monoclonal antibodies (detecting 17 positive samples only). In addition, HCMV was detected in association with a respiratory virus in 4/18 HCMV‐positive patients, and was found at a high concentration (>105 DNA copies/ml) in 3/16 (18.7%) patients with HCMV‐positive bronchoalveolar lavage samples and pneumonia. Coinfections and sequential infections by HCMV and respiratory viruses were significantly more frequent in patients with acute rejection and steroid treatment. In conclusion: (i) about 50% of respiratory tract infections of lung transplant recipients were associated with one or more respiratory viruses; (ii) hMPV largely predominates in bronchoalveolar lavage of symptomatic lung transplant recipients, thus suggesting a causative role in lower respiratory tract infections; (iii) RT‐PCR appears to be the method of choice for detection of respiratory viruses in lung transplant recipients, (iv) a high HCMV load in bronchoalveolar lavage is a risk factor for viral pneumonia, suggesting some measure of intervention for the control of viral infection. J. Med. Virol. 78:408–416, 2006. © 2006 Wiley‐Liss, Inc.

Keywords: human metapneumovirus, human cytomegalovirus, lung transplant recipients, respiratory tract viral infections, nasopharyngeal aspirates, bronchoalveolar lavage, reverse transcription‐polymerase chain reaction (RT‐PCR)

REFERENCES

  1. Bailey TC, Buller RS, Ettinger RA, Trulock EP, Gaudreault‐Keener M, Langlois TM, Fornoff JE, Cooper JD, Storch GA. 1995. Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. J Infect Dis 171: 1006–1010. [DOI] [PubMed] [Google Scholar]
  2. Billings JL, Hertz MI, Savik K, Wendt CH. 2002. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transplant 21: 559–566. [DOI] [PubMed] [Google Scholar]
  3. Bridges RD, Spray TL, Collins MH, Bowles NE, Towbin JA. 1998. Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 116: 617–623. [DOI] [PubMed] [Google Scholar]
  4. Coiras MT, Perez‐Brena T, Garcia ML, Casas I. 2003. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested‐PCR assay. J Med Virol 69: 132–144. [DOI] [PubMed] [Google Scholar]
  5. Garantziotis S, Howell DN, McAdams HP, Davis D, Henshaw NG, Palmer SM. 2001. Influenza pneumonia and association of bronchiolitis obliterans syndrome. Chest 119: 1277–1280. [DOI] [PubMed] [Google Scholar]
  6. Garbino I, Gerbase MW, Wunderli W, Deffernez C, Thomas Y, Rochat T, Ninet B, Schrenzel J, Yerly S, Perrin L, Social PM, Nicod L, Kaiser L. 2004. Lower respiratory viral illnesses. Improved diagnosis by molecular methods and clinical impact. Am J Respir Crit Care Med 170: 1197–1203. [DOI] [PubMed] [Google Scholar]
  7. Gerna G, Revello MG, Percivalle E, Morini F. 1992. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 30: 1232–1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gerna G, Baldanti F, Sarasini A, Furione M, Percivalle E, Revello MG, Zipeto D, Zella D, the Italian Foscarnet Study Group . 1994. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrob Agents Chemother 38: 38–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gerna G, Baldanti F, Lilleri D, Parea M, Torsellini M, Castiglioni B, Vitulo P, Pellegrini C, Viganò M, Grossi P, Revello MG. 2003. Human cytomegalovirus pp67 mRNAemia vs pp65 antigenemia in heart and lung transplant recipients: A prospective randomized controlled open‐label trial. Transplantation 75: 1012–1019. [DOI] [PubMed] [Google Scholar]
  10. Gerna G, Percivalle E, Lilleri D, Lozza L, Fornara C, Hahn G, Baldanti F, Revello MG. 2005. Dendritic‐cell infection by human cytomegalovirus is restricted to strains carrying functional UL131‐128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J Gen Virol 86: 275–284. [DOI] [PubMed] [Google Scholar]
  11. Glezen PW, Greenberg SB, Atmar RL, Piedra PA, Couch RB. 2000. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283: 499–505. [DOI] [PubMed] [Google Scholar]
  12. Hall CB. 2001. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 344: 1917–1928. [DOI] [PubMed] [Google Scholar]
  13. Husain AN, Siddiqui MT, Holmes EW, Chandrasekhar AJ, McCabe M, Radvany R, Garrity ER. 1999. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 159: 829–833. [DOI] [PubMed] [Google Scholar]
  14. Khalifah AP, Hachem RR, Chakinala MM, Schechtman KB, Patterson GA, Schuster DP, Mohanakumar T, Trulock EP, Walter MJ. 2004. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 170: 181–187. [DOI] [PubMed] [Google Scholar]
  15. Krinzman S, Basgoz R, Kradin R, Shepard JA, Flieder DB, Wright CD, Wain JC, Ginns LC. 1998. Respiratory syncytial virus‐associated infections in adult recipients of solid organ transplant. J Heart Lung Transplant 17: 202–210. [PubMed] [Google Scholar]
  16. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM III. 1997. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 114: 195–202. [DOI] [PubMed] [Google Scholar]
  17. Lozza L, Lilleri D, Percivalle E, Fornara C, Comolli G, Revello MG, Gerna G. 2005. Simultaneous quantification of human cytomegalovirus (HCMV)‐specific CD4+ and CD8+ T cells by a novel method using monocyte‐derived HCMV‐infected immature dendritic cells. Eur J Immunol 35: 1795–1804. [DOI] [PubMed] [Google Scholar]
  18. Marx A, Gary HE, Marston BJ, Erdman DD, Breiman RF, Torok TJ, Plouffe JF, File TM Jr, Anderson LJ. 1999. Parainfluenza virus infection among adults hospitalised for lower respiratory tract infections. Clin Infect Dis 29: 134–140. [DOI] [PubMed] [Google Scholar]
  19. Matar LD, McAdams HP, Palmer SM, Howell DN, Henshaw NG, Davis RD, Tapson VF. 1999. Respiratory viral infection in lung transplant recipients: Radiologic findings with clinical correlation. Radiology 213: 735–742. [DOI] [PubMed] [Google Scholar]
  20. McCurdy LH, Milstone A, Dummer S. 2003. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin. J Heart Lung Transplant 22: 745–753. [DOI] [PubMed] [Google Scholar]
  21. Ohori NP, Michaels MG, Jaffe R, Williams P, Yousern SA. 1995. Adenovirus pneumonia in lung transplant recipients. Hum Pathol 26: 1073–1079. [DOI] [PubMed] [Google Scholar]
  22. Palmer SM, Henshaw NG, Howell DN, Miller SE, Davis RD, Tapson VF. 1998. Community respiratory viral infection in adult lung transplant recipients. Chest 113: 944–950. [DOI] [PubMed] [Google Scholar]
  23. Percivalle E, Sarasini A, Visai L, Revello MG, Gerna G. 2005. Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell‐vial cultures by monoclonal antibodies. J Clin Microbiol 43: 3443–3446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ, Natonal Microbiology Laboratory, Canada; Canadian Severe Acute Respiratory Syndrome Study Team . 2003. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348: 1995–2005. [DOI] [PubMed] [Google Scholar]
  25. Riise GC, Andersson R, Bergstrom T, Lundmark A, Nilsson FN, Olofsson S. 2000. Quantification of cytomegalovirus DNA in BAL fluid: A longitudinal study in lung transplant recipients. Chest 118: 1653–1660. [DOI] [PubMed] [Google Scholar]
  26. Rovida F, Percivalle E, Zavattoni M, Torsellini M, Sarasini A, Campanini G, Paolucci S, Baldanti F, Revello MG, Gerna G. 2005. Monoclonal antibodies versus reverse transcription‐PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital. J Med Virol 75: 336–347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sanchez JL, Kruger RM, Paranjothi S, Trulock EP, Lynch JP, Hicks C, Shannon WD, Storch GA. 2001. Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation 72: 733–735. [DOI] [PubMed] [Google Scholar]
  28. Sarasini A, Percivalle E, Rovida F, Campanini G, Genini E, Torsellini M, Paolucci S, Baldanti F, Marchi A, Revello MG, Gerna G. Detection and pathogenicity of human metapneumovirus respiratory infection in pediatric Italian patients during a winter‐spring season. J Clin Virol (in press). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Steininger C, Aberle SW, Popow‐Kraupp T. 2001. Early detection of acute rhinovirus infections by a rapid reverse transcription‐PCR assay. J Clin Microbiol 39: 129–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tamm M, Aboyoun CL, Chhajed PN, Rainer S, Malouf MA, Glanville AR. 2004. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 170: 1120–1123. [DOI] [PubMed] [Google Scholar]
  31. van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7: 719–724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. van den Hoogen BG, van Doornum GJJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R, Osterhaus AD, Fouchier RA. 2003. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalised patients. J Infect Dis 188: 1571–1577. [DOI] [PubMed] [Google Scholar]
  33. van den Hoogen BG, Osterhaus ADME, Fouchier RAM. 2004. Clinical impact and diagnosis of human metapneumovirus infection. Ped Infect Dis J 23: S25–S32. [DOI] [PubMed] [Google Scholar]
  34. Vilchez RA, McCurry K, Dauber J, Iacono A, Keenan R, Zeevi A, Griffith B, Kusne S. 2001. The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 33: 2004–2008. [DOI] [PubMed] [Google Scholar]
  35. Vilchez RA, McCurry K, Dauber J, Iacono A, Griffith B, Fung J, Kusne S. 2002. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2: 287–291. [DOI] [PubMed] [Google Scholar]
  36. Vilchez RA, Dauber J, Kusne S. 2003. Infectious etilogy of bronchiolitis obliterans: The respiratory viruses connection‐ Myth or reality? Am J Transplant 3: 245–249. [DOI] [PubMed] [Google Scholar]
  37. Wend CH, Fox JM, Hertz MI. 1995. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 14: 479–485. [PubMed] [Google Scholar]
  38. Westall GP, Michaelidis A, Williams TJ, Snell GI, Kotsimbos TC. 2004. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: A longitudinal study of lung transplant recipients. J Infect Dis 190: 1076–1083. [DOI] [PubMed] [Google Scholar]
  39. Zavattoni M, Percivalle E, Cattaneo E, Revello MG, Torsellini M, Gerna G. 2003. Optimized detection of respiratory viruses in nasopharyngeal secretions. New Microbiologica 26: 133–140. [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES